Cerity Partners LLC Eli Lilly & CO Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cerity Partners LLC holds 580,520 shares of LLY stock, worth $437 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

580,520

Previous 530,429 9.44%

Holding current value

$437 Million

Previous $480 Million 7.09%

% of portfolio

1.15%

Previous 1.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $38.7 Million - $48.1 Million	50,091 Added 9.44%	580,520 $514 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $12.2 Million - $15.3 Million	-16,841 Reduced 3.08%	530,429 $480 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $21 Million - $28.1 Million	-35,491 Reduced 6.09%	547,270 $426 Million
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $187 Million - $220 Million	355,548 Added 156.48%	582,761 $340 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $14 Million - $19.3 Million	-32,262 Reduced 12.43%	227,213 $122 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $8.8 Million - $11.8 Million	25,080 Added 10.7%	259,475 $122 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $3.11 Million - $3.65 Million	10,003 Added 4.46%	234,395 $80.5 Million
Q4 2022 Feb 15, 2023	BUY	$321.55 - $374.67 $9.47 Million - $11 Million	29,448 Added 15.11%	224,392 $82.1 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $1.1 Million - $1.25 Million	3,699 Added 1.93%	194,944 $63 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $45.2 Million - $53.1 Million	162,110 Added 556.41%	191,245 $62 Million
Q1 2022 Apr 25, 2022	BUY	$234.69 - $291.66 $1.44 Million - $1.79 Million	6,130 Added 26.65%	29,135 $7.5 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2.67 Million - $3.31 Million	11,857 Added 106.36%	23,005 $5.62 Million
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $3,988 - $4,908	-18 Reduced 0.16%	11,148 $2.58 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $56,873 - $73,565	-315 Reduced 2.74%	11,166 $2.56 Million
Q1 2021 Aug 11, 2021	SELL	$164.32 - $212.72 $148,873 - $192,724	-906 Reduced 7.31%	11,481 $2.15 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $187,982 - $243,351	-1,144 Reduced 8.45%	12,387 $2.31 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $205,996 - $272,582	1,579 Added 13.21%	13,531 $2.29 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $578,446 - $669,078	3,956 Added 49.47%	11,952 $1.77 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $54,295 - $65,343	398 Added 5.24%	7,996 $1.31 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $43,334 - $53,635	-364 Reduced 4.57%	7,598 $1.06 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $85,322 - $105,679	-798 Reduced 9.11%	7,962 $1.05 Million
Q3 2019 Oct 30, 2019	BUY	$106.79 - $116.16 $433,887 - $471,958	4,063 Added 86.5%	8,760 $980,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $275,202 - $321,230	-2,484 Reduced 34.59%	4,697 $520,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $19,034 - $22,404	-171 Reduced 2.33%	7,181 $932,000
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $19,273 - $21,592	182 Added 2.54%	7,352 $851,000
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $47,137 - $58,913	549 Added 8.29%	7,170 $769,000
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $65,556 - $75,238	866 Added 15.05%	6,621 $565,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $411,346 - $485,566	-5,543 Reduced 49.06%	5,755 $445,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $387,248 - $415,368	4,726 Added 71.91%	11,298 $954,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $506,504 - $562,168	6,572	6,572 $562,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Eli Lilly & CO Transaction History